Regeneron PharmaceuticalsvsUnitedHealth

REGN and UNH stock compared: price, dividend, valuation and results, from SEC filings.

REGN

Regeneron Pharmaceuticals, Inc.

$945.53

Value $98.9B

-1.28%
REGN's page

UNH

UnitedHealth Group Incorporated

$349.91

Value $318B

-10.21%
UNH's page

Regeneron Pharmaceuticals (REGN) has a market value of $98.9B and UnitedHealth (UNH) $318B. Over the last year, with dividends, REGN moved +34.9% and UNH +12.1%. The P/E is 20.5 for REGN and 20.0 for UNH. Dividend yield: REGN 0.39%, UNH 2.59%.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    REGN$98.9B

    UNH$318B

    UNH is 3.2 times REGN

  • Revenue, 12 months

    REGN$16.9B

    UNH$450B

    UNH is 27 times REGN

  • Net income, 12 months

    REGN$4.8B

    UNH$15.9B

    UNH is 3.3 times REGN

  • Operating margin

    REGN28.8%

    UNH5.3%

    23.5 points apart

  • ROIC

    REGN12.2%

    UNH11.3%

    0.9 points apart

  • P/E

    REGN20.5

    UNH20.0

    About the same

  • Dividend yield

    REGN0.4%

    UNH2.6%

    2.2 points apart

  • 5-year return

    REGN+48.7%

    UNH-14.7%

    63.4 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

REGN+48.7%

UNH-14.7%

5010015020222023202420252026
Returns by period
PeriodREGNWith dividendsUNHWith dividends
1 year since November 17, 2025+34.9%Price +34.2%+12.1%Price +9.2%
3 years since November 17, 2023+18.9%+5.9% a yearPrice +17.8%-30.5%-11.4% a yearPrice -34.8%
5 years since November 17, 2021+48.7%+8.3% a yearPrice +47.3%-14.7%-3.1% a yearPrice -22.1%
10 years since November 18, 2016+140.1%+9.2% a yearPrice +137.9%+176.5%+10.7% a yearPrice +134.1%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

REGNRegeneron PharmaceuticalsUNHUnitedHealth

Valuation

REGNUNH
Valuation
Price$945.53$349.91
Market value$98.9B$318B
Enterprise value (EV)$92.3B$363B
P/E20.520.0
P/E, 5-year median18.625.0
P/B3.03.1
EV/EBIT19.015.2
Free cash flow yield3.9%7.2%

Results and growth

REGNUNH
Results and growth
Revenue, 12 months$16.9B$450B
Net income, 12 months$4.8B$15.9B
Free cash flow, 12 months$3.8B$22.8B
Earnings per share, 12 months$45.30$17.52
Revenue growth, year on year1.0%11.8%
Revenue growth a year, past+11.0%over 5 years+11.7%over 5 years
EPS growth a year, past+6.3%over 5 years-3.8%over 5 years

Margins and returns on capital

REGNUNH
Margins and returns on capital
Gross margin–88.3%
Operating margin28.8%5.3%
Net margin28.5%3.5%
ROIC12.2%11.3%
ROE15.2%15.5%

Balance sheet

REGNUNH
Balance sheet
Cash$9.3B$28.5B
Total debt$2.7B$74.3B
Net debt / EBITDA-1.21.6
Interest cover104.2×6.2×

Dividends and buybacks

REGNUNH
Dividends and buybacks
Dividend yield0.4%2.6%
Dividend per share, 12 months$3.70$9.06
Dividend growth a year, past–+12.6%over 5 years
Buyback yield3.5%1.8%
Shareholder yield3.9%4.3%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: REGN or UNH

Didn't find what you were looking for?

Ask us
Which is bigger, Regeneron Pharmaceuticals or UnitedHealth?

By market value, UnitedHealth ($318B) is about 3.2 times Regeneron Pharmaceuticals ($98.9B), at today's prices.

How did REGN and UNH stock do over the last 10 years?

Since November 18, 2016, REGN's price moved +137.9% and UNH's +134.1%. With dividends: REGN +140.1% (+9.2% a year), UNH +176.5% (+10.7% a year). Past returns do not predict future ones.

Which pays the higher dividend, REGN or UNH?

The dividend yield at today's price is 0.39% for Regeneron Pharmaceuticals and 2.59% for UnitedHealth. Over the last twelve months they paid $3.70 and $9.06 per share.

What is the P/E of REGN and UNH?

At today's price, the P/E is 20.5 for REGN and 20.0 for UNH. The median of the last five years was 18.6 and 25.0, which shows where each stands against its own past.

Which has the higher profit margins, Regeneron Pharmaceuticals or UnitedHealth?

Over the last twelve months, the net margin was 28.5% for Regeneron Pharmaceuticals and 3.5% for UnitedHealth, and the operating margin 28.8% and 5.3%. Revenue was $16.9B and $450B.

Which is the better investment, Regeneron Pharmaceuticals or UnitedHealth?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.